|ARTIGO_COVID-19TherapeuticApproaches.pdf||1,49 MB||Adobe PDF||View/Open|
|Title:||COVID-19 : therapeutic approaches description and discussion|
|Authors:||Trindade, Guilherme G.|
Caxito, Samyra M. C.
Xavier, Alessandra Rejane E. O.
Xavier, Mauro A. S.
|Publisher:||Academia Brasileira de Ciências|
|Citation:||TRINDADE, Guilherme G. et al. COVID-19: therapeutic approaches description and discussion. Anais da Academia Brasileira de Ciências, Rio de Janeiro, v. 92, n. 2, e20200466, 2020. DOI: https://doi.org/10.1590/0001-3765202020200466. Disponível em: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652020000300902&lng=en&nrm=iso. Acesso em: 11 fev. 2021. Epub June 12, 2020.|
|Abstract:||COVID-19 emerged in December 2019 in China, and since then, has disrupted global public health and changed economic paradigms. In dealing with the new Coronavirus, SARS-CoV-2, the world has not faced such extreme global fragility since the “Spanish flu” pandemic in 1918. Researchers globally are dedicating efforts to the search for an effective treatment for COVID-19. Drugs already used in a clinical setting for other pathologies have been tested as a new therapeutic approach against SARS-CoV-2, setting off a frenzy over the preliminary data of different studies. This work aims to compile and discuss the data published thus far. Despite the potential effects of some antivirals and antiparasitic against COVID-19, clinical studies must confirm real effectiveness. However, non-pharmacological approaches have proven to be the most efficient strategy to date.|
|Appears in Collections:||FAR - Artigos publicados em periódicos|
UnB - Covid-19
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.